هفته نامه اطلاع رسانی اختراعات منتشر شده در سازمان جهانی مالکیت فکری
		invbazaar.com

سال	هفته	ID	Title	ApplNo	IPC	Applicant	Subgroup	زیر گروه	رشته	شرح	Description
2025	48	WO/2025/152767	RECOMBINANT MICROORGANISM FOR FIXING CARBON DIOXIDE AND USE THEREOF	CN2024/144341	C07K 14/405	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/162944	NOVEL COMPOUNDS	EP2025/052148	C07K 7/06	DSM IP ASSETS B.V.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/165389	METALLOPROTEINS AS A TUNABLE SCAFFOLD FOR CONSTRUCTING QUANTUM BITS AND DITS FOR USE IN QUANTUM INFORMATION STORAGE AND PROCESSING	US2024/028407	C07K 14/195	OHIO STATE INNOVATION FOUNDATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/200632	INSECTICIDAL PROTEIN AND USE THEREOF	CN2024/141426	C07K 14/325	BEIJING DABEINONG BIOTECHNOLOGY CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/221728	LTBR BINDING MOLECULES AND USES THEREOF	US2025/024681	C07K 16/28	JANSSEN BIOTECH, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/221736	LTBR BINDING MOLECULES AND USES THEREOF	US2025/024690	C07K 16/18	JANSSEN BIOTECH, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/226775	COMPOSITIONS AND METHODS FOR BINDING TO COVALENT PEPTIDE CONJUGATES	US2025/025907	C07K 16/28	NEW YORK UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/230843	KIR BINDING ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF	US2025/026470	C07K 16/28	BIOLEGEND, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/240992	AGENTS FOR TREATMENT OF CONDITIONS ASSOCIATED WITH OPTIC ATROPHY 1	AU2025/050177	C07K 14/00	PYC THERAPEUTICS LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/240993	IMPROVED CELL PENETRATING PEPTIDES AND RELATED COMPOSITIONS AND METHODS	AU2025/050178	C07K 14/00	PYC THERAPEUTICS LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241018	BIOINSPIRED PEPTIDE AND USE FOR THE TREATMENT OF PERIORBITAL HYPERPIGMENTATION (DARK CIRCLES)	BR2025/050186	C07K 7/08	BIOINTECH BIOTECNOLOGIA	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241119	FUSION PROTEIN AND USE THEREOF	CN2024/094774	C07K 19/00	SHENZHEN UNIVERSITY OF TECHNOLOGY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241148	COMPOUNDS AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF	CN2024/094947	C07K 5/097	JUNMO (BEIJING) BIOTHERAPEUTICS CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241209	MUTANT OF RSV PRE-FUSION F PROTEIN, AND PREPARATION AND USE THEREOF	CN2024/096123	C07K 14/135	SUZHOU JUWEI BIOTECH CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241210	RSV PRE-F MUTANT, PRODUCTION METHOD THEREFOR AND USE THEREOF	CN2024/096145	C07K 14/135	SUZHOU JUWEI BIOTECH CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241665	IMPROVED T CELL AND USE THEREOF	CN2025/082078	C07K 14/715	NANJING MIRACLE BIOTECHNOLOGY CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241702	HLA-G-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF	CN2025/085669	C07K 16/28	HEFEI TG IMMUNOPHARMA CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241703	HIGH-AFFINITY B7H7 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF	CN2025/085670	C07K 16/28	HEFEI TG IMMUNOPHARMA CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241839	MONOCLONAL ANTIBODY BINDING TO MICROTUBULE-ASSOCIATED PROTEIN TAU PHOSPHORYLATED AT THREONINE 217 AND USE THEREOF	CN2025/091505	C07K 16/18	HKIG IMMUNE TECHNOLOGY (HANGZHOU) LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/241860	PROCESS FOR PREPARING HUMAN IMMUNOGLOBULIN FORMULATION FOR INTRAVENOUS INJECTION	CN2025/092192	C07K 16/00	GUANGDONG DANXIA BIOPHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242039	ANTI-CDH17 ANTIBODY, ANTIBODY-DRUG CONJUGATE THEREOF, AND USE THEREOF	CN2025/095728	C07K 16/28	HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242064	NANOANTIBODY TARGETING PHOSPHATIDYLINOSITOL PROTEOGLYCAN 3 AND USE THEREOF	CN2025/095901	C07K 16/44	GUORUI (GUANGZHOU) BIOTECHNOLOGY CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242073	DOUBLE-TARGET CHIMERIC ANTIGEN RECEPTOR, IMMUNE EFFECTOR CELL, AND USE	CN2025/095963	C07K 19/00	SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242074	ANTIBODY MOLECULE SPECIFICALLY BINDING TO CGRP RECEPTOR, AND USE THEREOF	CN2025/095966	C07K 16/28	BIYOPHARMA CO., LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242090	PREPARATION METHODS FOR CAMPTOTHECIN DERIVATIVE AND INTERMEDIATE THEREOF	CN2025/096055	C07K 7/06	KEYMED BIOSCIENCES (CHENGDU) CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242091	ANTIBODY AGAINST CEACAM5, AND USE THEREOF	CN2025/096066	C07K 16/30	KEYMED BIOSCIENCES (CHENGDU) CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242094	BDCA2-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF	CN2025/096081	C07K 16/28	SHENZHEN KEXING PHARMACEUTICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242100	ANTIBODY AGAINST CDH17 AND USE THEREOF	CN2025/096099	C07K 16/28	KEYMED BIOSCIENCES (CHENGDU) CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242151	PROTEOLYSIS TARGETING CHIMERA COMPOUNDS, COMPOSITIONS AND METHODS THEREOF	CN2025/096459	C07K 16/46	SHENZHEN TARGETRX, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242188	METABOLICALLY STABLE ANTI-DRUG-RESISTANT MAIN PROTEASE INHIBITOR AND USE THEREOF IN PREPARATION OF ANTIVIRAL DRUG	CN2025/096704	C07K 5/062	SHANGHAI INSTITUTE OF INFECTIOUS DISEASES AND BIOSECURITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242206	PD-L1-BINDING-PEPTIDE-BASED MULTIFUNCTIONAL MOLECULE	CN2025/096824	C07K 19/00	SUZHOU ALPHAMAB CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242209	FUSION POLYPEPTIDE AND USE THEREOF	CN2025/096841	C07K 14/705	ADLAI NORTYE BIOPHARMA CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242212	ANTI-SSTR2 ANTIBODIES	CN2025/096859	C07K 16/28	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242218	POLYPEPTIDE AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF	CN2025/096922	C07K 14/00	SHANGHAI HANSOH BIOMEDICAL CO., LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242618	BRONCHIECTASIS TREATMENT	EP2025/063724	C07K 16/24	MEDIMMUNE LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242619	TREATMENT FOR MUCUS PLUGGING	EP2025/063725	C07K 16/24	MEDIMMUNE LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242652	PREGNANCY ASSOCIATED PLASMA PROTEIN-A (PAPPA) BINDING PROTEINS	EP2025/063798	C07K 16/40	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242685	OPTIMIZED ANTI-AGR2 ANTIBODY	EP2025/063879	C07K 16/40	THABOR THERAPEUTICS	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242726	Antibody binding to FGFR1 and conjugates comprising the same	EP2025/063974	C07K 16/28	ONCONICK LTD.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242736	ANTIBODIES SPECIFIC TO HUMAN HMGI-C ANTIGEN AND USE THEREOF	EP2025/063992	C07K 16/24	PERICARD CHECK GMBH	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242827	BISPECIFIC ANTIBODY AGAINST PD-L1 AND CD137 IN COMBINATION THERAPY	EP2025/064194	C07K 16/28	GENMAB A/S	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242842	DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD137/PD-L1 ANTIGEN-BINDING PROTEIN	EP2025/064221	C07K 16/28	INVOX PHARMA LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242843	DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD137/PD-L1 ANTIGEN-BINDING PROTEIN	EP2025/064225	C07K 16/28	INVOX PHARMA LIMITED	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242900	COACERVATE-FORMING REAGENTS AND METHODS	EP2025/064356	C07K 7/06	PARTITIONBIO LTD	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242910	IL18R AGONIST ANTIBODIES AND USES THEREOF	EP2025/064388	C07K 16/28	EGLE THERAPEUTICS	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/242914	ENGINEERING CASSAVA FOR IMPROVED GROWTH AND YIELD	EP2025/064398	C07K 14/415	UNIVERSITY OF KAISERSLAUTERN-LANDAU	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/243217	CRYSTAL FORMS OF PEPTIDE MOLECULES	IB2025/055266	C07K 7/06	JANSSEN PHARMACEUTICA NV	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/243241	METHODS FOR TREATING MULTIPLE MYELOMA	IB2025/055316	C07K 16/28	JANSSEN BIOTECH, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/243243	BISPECIFIC ANTIBODY TARGETING EMR2 (CD312) AND THE T-CELL RECEPTOR TRBV19	IB2025/055320	C07K 16/28	JANSSEN BIOTECH, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/243970	NICOTINAMIDE RIBOSIDE TRANSPORTER MUTANT	JP2025/017984	C07K 14/32	KANEKA CORPORATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/243994	MACROCYCLIC COMPOUND INCLUDING PEPTIDE STRUCTURE AND METHOD FOR PRODUCING SAME	JP2025/018085	C07K 5/083	THE UNIVERSITY OF TOKYO	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244097	IMPROVED ANTI-FAP ALPHA-CHIMERIC ANTIGEN RECEPTOR	JP2025/018562	C07K 16/28	OPTIEUM BIOTECHNOLOGIES INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244098	ANTIBODY AGAINST sPLA2-XIIA AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	JP2025/018576	C07K 16/40	THE UNIVERSITY OF TOKYO	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244108	NOVEL FLUORESCENT LABELING METHOD	JP2025/018617	C07K 1/13	THE UNIVERSITY OF TOKYO	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244125	NOVEL POLYPEPTIDE	JP2025/018727	C07K 19/00	PIIF TAZUKE-KOFUKAI	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244201	METHOD FOR TREATMENT OF ADVANCED OR METASTATIC SOLID CANCER USING ANTI-CD47 ANTIBODY	KR2024/015638	C07K 16/28	IMMUNEONCIA THERAPEUTICS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244351	NOVEL PROMOTER AND METHOD FOR PRODUCING L-ISOLEUCINE BY USING SAME	KR2025/006594	C07K 14/34	CJ CHEILJEDANG CORPORATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244356	VARIANT OF PROTEIN AND METHOD FOR PRODUCING L-ISOLEUCINE BY USING SAME	KR2025/006627	C07K 14/34	CJ CHEILJEDANG CORPORATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244414	NOVEL CYCLIC LIPOPEPTIDE COMPOUND AND USE THEREOF	KR2025/006898	C07K 7/64	SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244454	NOVEL PROTEIN OR POLYNUCLEOTIDE VARIANT AND METHOD FOR PRODUCING L-LYSINE USING SAME	KR2025/007009	C07K 14/34	CJ CHEILJEDANG CORPORATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/244462	MONOCLONAL ANTIBODY TARGETING GFRAL AND USE THEREOF	KR2025/007020	C07K 16/28	KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245092	ANTI-NGF ANTIBODIES AND USES THEREOF	US2025/030169	C07K 16/22	INVETX, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245111	IMMUNORECEPTOR TARGETING PROTEINS AND RELATED METHODS	US2025/030194	C07K 14/705	FLAGSHIP PIONEERING INNOVATIONS VII, LLC	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245146	ANTI-APOE ANTIBODIES: COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME	US2025/030242	C07K 16/28	NEXTCURE, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245150	ANTI-PD-1 X IL-25 BISPECIFIC ANTIBODY TO TREAT CANCER	US2025/030248	C07K 16/24	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245176	MULTISPECIFIC ANTIBODY CONSTRUCTS	US2025/030296	C07K 16/28	BRISTOL-MYERS SQUIBB COMPANY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245200	PONSEGROMAB FOR USE IN TREATING CACHEXIA IN CANCER PATIENTS	US2025/030336	C07K 16/22	PFIZER INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245209	COMPOSITIONS AND METHODS FOR MAKING AMPHIPATHIC POLYPEPTIDES	US2025/030350	C07K 7/06	UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245252	NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR USE IN PAIN MANAGEMENT AND/OR SUBSTANCE USE DISORDERS	US2025/030410	C07K 14/68	ENDEVICA BIO, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245258	NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR MODULATING WEIGHT GAIN	US2025/030419	C07K 14/665	ENDEVICA BIO, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245264	ANTI-B7-H3 ANTIBODIES AND METHODS OF USE THEREOF	US2025/030429	C07K 16/28	BRIAPRO THERAPEUTICS CORP.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245267	A MULTI-ANTIGEN DIAGNOSTIC IMMUNOASSAY AND VACCINE AGAINST BABESIOSIS	US2025/030433	C07K 14/44	TRUSTEES OF TUFTS COLLEGE	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245271	ANTI-NKG2D ANTIBODIES AND METHODS OF USE THEREOF	US2025/030438	C07K 16/28	DRAGONFLY THERAPEUTICS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245288	NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND USES THEREOF	US2025/030457	C07K 5/117	ENDEVICA BIO, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245306	METHODS AND COMPOSITIONS FOR PRODUCING MEIOTIC CELLS	US2025/030494	C07K 14/47	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245317	METHODS OF TREATING COLORECTAL CANCER USING AN ANTI-CTLA4 ANTIBODY	US2025/030515	C07K 16/28	AGENUS INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245333	POLYPEPTIDES FOR CO-ENGAGEMENT OF TYPE I AND II FC RECEPTORS TO MEDIATE ANTI-INFLAMMATORY ACTIVITIES AND USE THEREOF	US2025/030553	C07K 16/28	THE ROCKEFELLER UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245371	POLYPEPTIDES COMPRISING PROTEASE-RESISTANT FC DOMAIN, COMPOSITIONS AND USES THEREOF	US2025/030631	C07K 16/28	SEISMIC THERAPEUTIC, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245374	PEPTIDIC CHIMERIC ANTIGEN RECEPTOR EFFECTOR CELL ADAPTERS AND USES THEREOF	US2025/030638	C07K 14/71	THE NEMOURS FOUNDATION	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245386	KIR3DL2 AS AN ANTI-CANCER TARGET	US2025/030661	C07K 16/28	LA JOLLA INSTITUTE FOR IMMUNOLOGY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245417	CHIMERIC ANTIGEN RECEPTORS (CARS) TARGETING MET	US2025/030706	C07K 14/705	YALE UNIVERSITY	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245483	METHODS AND COMPOSITIONS	US2025/030832	C07K 7/06	FLAGSHIP PIONEERING INNOVATIONS VII, LLC	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245494	TUMOR-TARGETED SPLIT IL12 RECEPTOR AGONISTS	US2025/030852	C07K 16/46	REGENERON PHARMACEUTICALS, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی
2025	48	WO/2025/245508	ANTI-TNF-LIKE LIGAND 1A (TL1A) ANTIBODIES	US2025/030878	C07K 16/28	XENCOR, INC.	CHEMISTRY; METALLURGY	علم شیمی؛ متالورژی	شیمی